STOCK TITAN

Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology firm, will participate in the H.C. Wainwright Global Investment Conference from May 23 to 26, 2022 in Miami, Florida. The company is set to host a fireside chat on May 24, 2022, at 2:30 PM ET. Investors can access the conference call via a webcast on their website, where replays will be available for 90 days. Axcella focuses on innovative therapies for complex diseases using endogenous metabolic modulators.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that management will participate in a fireside chat and one-on-one meetings at the H.C. Wainwright Global Investment Conference taking place May 23 – 26, 2022 both virtually and in-person in Miami, Florida.

Details for the fireside chat are as follows:

Date:

         

Tuesday, May 24, 2022

Time:

         

2:30pm Eastern Time

Webcast:

         

https://journey.ct.events/view/aab5cfb6-d963-46cc-91d6-a795c1b2436c

The conference call webcast will be accessible in the Investors & News section on the company’s website at www.axcellatx.com. An archive of the webcast replay will be available on the Company’s website for up to 90 days.

To request a one-on-one in-person or virtual meeting, please register here.

Internet Posting of Information
Axcella uses the “Investors and News” section of its website, www.axcellatx.com, as a means of disclosing material nonpublic information, to communicate with investors and the public, and for complying with its disclosure obligations under Regulation FD. Such disclosures include, but may not be limited to, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, and public conference calls and webcasts. The information that we post on our website could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

About Axcella Therapeutics (Nasdaq: AXLA)
Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). The company’s product candidates are comprised of EMMs and derivatives that are engineered in distinct combinations and ratios to reset multiple biological pathways, improve cellular energetics, and restore homeostasis. Axcella’s pipeline includes lead therapeutic candidates in Phase 2 development for the treatment of Long COVID, NASH, and the reduction in risk of OHE recurrence. The company’s unique model allows for the evaluation of its EMM compositions through non-IND clinical studies or IND clinical trials. For more information, please visit www.axcellatx.com.

Ashley Robinson

arr@lifesciadvisors.com

(617) 430-7577

Source: Axcella Therapeutics

FAQ

When is Axcella Therapeutics participating in the H.C. Wainwright Global Investment Conference?

Axcella Therapeutics will participate in the H.C. Wainwright Global Investment Conference from May 23 to 26, 2022.

What time is Axcella's fireside chat at the H.C. Wainwright Conference?

Axcella's fireside chat is scheduled for May 24, 2022, at 2:30 PM Eastern Time.

How can I access the webcast of Axcella's conference call?

The webcast of Axcella's conference call can be accessed through their website at www.axcellatx.com.

What is the focus of Axcella Therapeutics?

Axcella Therapeutics is focused on treating complex diseases using multi-targeted endogenous metabolic modulator compositions.

Is there a way to request a meeting with Axcella's management during the conference?

Yes, you can request a one-on-one in-person or virtual meeting with Axcella's management by registering through their conference link.

Axcella Health Inc.

NASDAQ:AXLA

AXLA Rankings

AXLA Latest News

AXLA Stock Data

1.18M
1.07M
15.8%
55.8%
2.65%
Biotechnology
Healthcare
Link
United States
Cambridge